期刊
LEUKEMIA
卷 14, 期 1, 页码 183-187出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.leu.2401617
关键词
multiple myeloma; p16 gene; methylation; cell cycle
The p16 gene competes with cyclin D for binding to CDK4/CDK6 and therefore inhibits CDK4/6 complex kinase activity, resulting in dephosphorylation of pRb and related GI growth arrest. Inactivation of this gene has been involved in a variety of tumors by different mechanisms: homozygous/hemyzygous deletions, point mutations and methylation of a 5' CpG island into exon E1 alpha of the p16 gene. Homozygous deletions have been rarely found in multiple myeloma (MM) and no point mutations have been reported. Two recent studies have reported a high prevalence of methylation in the exon E1 alpha of the p16 gene, but included only a small number of cases. We have analyzed the methylation pattern of exon E1 alpha of the pie gene in 101 untreated MM and five primary plasma cell leukemias (PCL). A PCR assay, relying on the inability of some restriction enzymes to digest methylated sequences, was used to analyze the methylation status. Southern blot analysis was used to confirm these results. Forty-one of 101 MM patients (40.5%) as well as four of the five (80%) primary PCL patients had shown methylation of the exon E1 alpha. Our study confirms that hypermethylation of the pie gene is a frequent event in MM.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据